Skip to main content
. 2009 Dec 29;3:253–268. doi: 10.2147/dddt.s4505

Table 3.

Medications with potential for significant drug interactions

Chemotherapeutic agents Calcium channel blockers Others
Doxorubicin Amlodipine Quinidine
Etoposide (BP-16) Diltiazem Buspirone
Tamoxifen Felodipine Zolpidem
Vinblastine Isradipine Nefazodone
Vincristine Lercanidipine Trazodone
Nicardipine Carbamazepine
Nifedipine Glucocorticoids
Nimodipine Rifabutin
Nisoldipine
Nitrendipine
Verapamil
HMG CoA reductase inhibitors Benzodiazipines Macrolide antibiotics
Atorvastatin >60 mg/day Alprazolam (except azithromycin, dirithromycin and roxithromycin)
Lovastatin Diazepam
Simvastatin Midazolam
Rosuvastatin Triazolam
Protease inhibitors Immunosuppressants Azole antifungals (except fluconazole and topical antifungals)
Ritonavir Cyclosporine
Indinavir Tacrolimus